Zdrowie i gospodarka · 26/08/2016

FDA Announces Final Guidance for Microbiology Data in Antibacterial Drug Development

The US Food and Drug Administration (FDA) has released a final guidance document to help pharmaceutical companies collect and present microbiology data during the development of antibacterial drugs, building on a draft released in 2009.